Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors

Details for Australian Patent Application No. 2007280214 (hide)

Owner Glaxo Group Limited

Inventors Aston, Nicola Mary; Edlin, Christopher David; Chudasama, Reshma Manesh; Allen, David George; Day, Caroline Jane; Barnett, Rodger Phillip; Kindon, Leanda Jane; Trivedi, Naimisha

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007280214

PCT Pub. Number WO2008/015416

Priority 0706790.3 05.04.07 GB; 0615286.2 01.08.06 GB; 0714815.8 30.07.07 GB

Filing date 31 July 2007

Wipo publication date 7 February 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/015416 Priority application(s): WO2008/015416

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007280216-Pluripotent cells from rat and other species

2007280200-Jewelry